bazedoxifene acetate has been researched along with 4-[6-[4-(methoxycarbonylamino)phenyl]-4-(4-morpholinyl)-1-pyrazolo[3,4-d]pyrimidinyl]-1-piperidinecarboxylic acid methyl ester in 1 studies
Studies (bazedoxifene acetate) | Trials (bazedoxifene acetate) | Recent Studies (post-2010) (bazedoxifene acetate) | Studies (4-[6-[4-(methoxycarbonylamino)phenyl]-4-(4-morpholinyl)-1-pyrazolo[3,4-d]pyrimidinyl]-1-piperidinecarboxylic acid methyl ester) | Trials (4-[6-[4-(methoxycarbonylamino)phenyl]-4-(4-morpholinyl)-1-pyrazolo[3,4-d]pyrimidinyl]-1-piperidinecarboxylic acid methyl ester) | Recent Studies (post-2010) (4-[6-[4-(methoxycarbonylamino)phenyl]-4-(4-morpholinyl)-1-pyrazolo[3,4-d]pyrimidinyl]-1-piperidinecarboxylic acid methyl ester) |
---|---|---|---|---|---|
10 | 0 | 9 | 17 | 0 | 13 |
Protein | Taxonomy | bazedoxifene acetate (IC50) | 4-[6-[4-(methoxycarbonylamino)phenyl]-4-(4-morpholinyl)-1-pyrazolo[3,4-d]pyrimidinyl]-1-piperidinecarboxylic acid methyl ester (IC50) |
---|---|---|---|
Phosphatidylinositol 3-kinase regulatory subunit alpha | Homo sapiens (human) | 0.5152 | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Homo sapiens (human) | 0.7706 | |
Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.1749 | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Homo sapiens (human) | 6.315 | |
Rapamycin-insensitive companion of mTOR | Homo sapiens (human) | 0.005 | |
Regulatory-associated protein of mTOR | Homo sapiens (human) | 0.005 | |
Target of rapamycin complex 2 subunit MAPKAP1 | Homo sapiens (human) | 0.005 | |
Target of rapamycin complex subunit LST8 | Homo sapiens (human) | 0.005 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
1 other study(ies) available for bazedoxifene acetate and 4-[6-[4-(methoxycarbonylamino)phenyl]-4-(4-morpholinyl)-1-pyrazolo[3,4-d]pyrimidinyl]-1-piperidinecarboxylic acid methyl ester
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |